Relation between age and cardiovascular disease in men and women with diabetes compared with non-diabetic people: a population-based retrospective cohort study
Booth GL, Kapral MK, Fung K, Tu JV. Lancet. 2006; 368(9529):29-36.
Publications
Warfarin prescribing in atrial fibrillation: the impact of physician, patient and hospital characteristics
Choudhry NK, Soumerai SB, Normand SL, Ross-Degnan D, Laupacis A, Anderson GM. Am J Med. 2006; 119(7):607-15.
A comparison of propensity score methods: a case-study estimating the effectiveness of post-AMI statin use
Austin PC, Mamdani MM. Stat Med. 2006; 25(12):2084-106.
Public versus private institutional performance reporting: what is mandatory for quality improvement?
Guru V, Fremes SE, Naylor CD, Austin PC, Shrive FM, Ghali WA, Tu JV; Cardiac Care Network of Ontario. Am Heart J. 2006; 152(3):573-8.
Effectiveness and efficiency of different guidelines on statin treatment for preventing deaths from coronary heart disease: modelling study
Manuel DG, Kwong K, Tanuseputro P, Lim J, Mustard CA, Anderson GM, Ardal S, Alter DA, Laupacis A. BMJ. 2006; 332(7555):1419. Epub 2006 May 31.
Factors explaining the under-use of reperfusion therapy among ideal patients with ST-segment elevation myocardial infarction
Alter DA, Ko DT, Newman A, Tu JV. Eur Heart J. 2006; 27(13):1539-49. Epub 2006 Jun 7.
Study design to determine the effects of widespread restrictions on hospital utilization to control an outbreak of SARS in Toronto, Canada
Schull MJ, Stukel TA, Vermeulen MJ, Alter D. Exp Rev Pharmacoecon Outcome Res. 2006; 6(3):285-92.
Persistence with bisphosphonate therapy in older people
Melo M, Qiu F, Sykora K, Juurlink D, Laupacis A, Mamdani M. J Am Geriatr Soc. 2006; 54(6):1015-6.
Registry of the Canadian Stroke Network: Report on the 2002/03 Ontario Stroke Audit
How many “me-too” drugs are enough? The case of physician preferences for specific statins
Austin PC, Mamdani MM, Juurlink DN. Ann Pharmacother. 2006; 40(6):1047-51. Epub 2006 May 16.